Clinical Studies on Levitra for Female Patients

©2008 Bayer HealthCare Pharmaceuticals Inc.Printed in U.S.A. Repackaged by: APHENA PHARMA SOLUTIONS - TN Cookeville, TN 3850620111027AW Read the Patient Information about LEVITRA before you start taking it and again each time you get a refill. You may also find it helpful to share this information with your partner.

• The effectiveness of Levitra in women is not backed by conclusive evidence.
• Some authorities recommend against using PDE5 inhibitors in women without proper clinical trials.
• Off-label use of Levitra in women carries potential legal and health risks.
• Promising experimental results require cautious interpretation until verified through large studies.
• Female sexual dysfunction is complex and often requires multimodal treatment approaches.
• The focus is shifting towards personalized medicine for better outcomes.
• Women should leverage a holistic approach—medical, psychological, and relational.
• Increasing awareness and research funding are essential for women's sexual health innovations.
• Overall, safer, evidence-based options remain the priority in treatment strategies.

This leaflet does not take the place of talking with your doctor.

• Levitra is part of a class of drugs called phosphodiesterase inhibitors.
• The mechanism of action involves increasing blood circulation, which might affect sexual response.
• Women do not have PDE5 enzymes in the same concentration as men, complicating its effects.
• Some studies have tested whether Levitra can improve sexual dysfunction in women with certain health issues.
• It is essential to monitor for side effects and interactions when considering Levitra for women.
• Sexual health is multifaceted, involving hormonal, psychological, and relational factors.
• Physicians emphasize evidence-based use of medications in treating sexual dysfunction.
• Legal and ethical considerations restrict off-label use in many countries.
• Alternative evidence-supported options include therapy, hormone therapy, and lifestyle adjustments.

You and your doctor should talk about LEVITRA when you start taking it and at regular checkups. If you do not understand the information, or have questions, talk with your doctor or pharmacist. WHAT IMPORTANT INFORMATION SHOULD YOU KNOW ABOUT LEVITRA?

Shop Medications

LEVITRA has not been evaluated in patients with severe hepatic impairment (Child-Pugh C) (see CLINICAL PHARMACOLOGY, Metabolism and ExcretionWARNINGS and PRECAUTIONS). Renal Impairment: For patients with mild (CLcr = 50-80 ml/min), moderate (CLcr = 30-50 ml/min), or severe (CLcr<30 ml/min) renal impairment, no dose adjustment is required. LEVITRA has not been evaluated in patients on levitra generic quality renal dialysis (see CLINICAL PHARMACOLOGY, Metabolism and Excretion and PRECAUTIONS). Concomitant Medications: The dosage of LEVITRA may require adjustment in patients receiving potent CYP3A4 inhibitors such as ketoconazole, itraconazole, ritonavir, indinavir, saquinavir, atazanavir, and clarithromycin as well as in other patients receiving moderate CYP3A4 inhibitors such as erythromycin (see WARNINGS, PRECAUTIONS, Drug Interactions). For ritonavir, a single dose of 2.5 mg LEVITRA should not be exceeded in a 72-hour period.

Priligy Generic Dapoxetine

For indinavir, saquinavir, atazanavir, ketoconazole 400 mg daily, itraconazole 400 mg daily, and clarithromycin, a single dose of 2.5 mg LEVITRA should not be exceeded in a 24-hour period. For ketoconazole 200 mg daily, itraconazole 200 mg daily, and erythromycin, a single dose of 5 mg LEVITRA should not be exceeded in a 24-hour period. For alpha-blockers, caution is advised when PDE5 inhibitors, including LEVITRA, are used concomitantly with alpha-blockers because of the potential for an additive effect on blood pressure. In some patients, concomitant use of these two drug classes can lower blood pressure significantly (see PRECAUTIONS,Alpha-blockers and Drug Interactions) leading to symptomatic hypotension (e.g., fainting). Concomitant treatment should be initiated only if the patient is stable on his alpha blocker therapy. LEVITRA can cause your blood pressure to drop suddenly to an unsafe level if it is taken with certain other medicines. With a sudden drop in blood pressure, you could get dizzy, faint, or have a heart attack or stroke. use recreational drugs called “poppers” like amyl nitrate and butyl nitrate.

Product	Dosage	Quantity + Bonus	Price
Levitra Soft Tabs	20mg	90 + 6 Pills	241.31€ 229.82€	Buy
Levitra Professional	20mg	120 + 4 Pills	348.44€ 331.85€	Buy
Levitra Generic	20mg	90 + 8 Pills	180.78€ 172.17€	Buy
Levitra Generic	40mg	120 + 8 Pills	302.37€ 287.97€	Buy
Levitra Generic	60mg	30 + 2 Pills	109.43€ 104.22€	Buy
Levitra Generic	20mg	30 + 4 Pills	70.59€ 67.23€	Buy
Levitra Generic	10mg	60 + 6 Pills	112.98€ 107.60€	Buy
Levitra Professional	20mg	360 + 6 Pills	914.63€ 871.08€	Buy
Levitra Generic	10mg	270 + 10 Pills	338.09€ 321.99€	Buy
Levitra Generic	20mg	20 Pills	52.63€ 50.12€	Buy
Levitra Original	20mg	12 Pills	81.99€ 78.09€	Buy
Levitra Generic	20mg	10 Pills	31.49€ 29.99€	Buy
Levitra Original	20mg	92 + 4 Pills	406.22€ 386.88€	Buy
Levitra Professional	20mg	10 Pills	62.37€ 59.40€	Buy
Levitra Professional	20mg	20 Pills	101.00€ 96.19€	Buy
Levitra Professional	20mg	90 + 2 Pills	304.49€ 289.99€	Buy
Levitra Generic	60mg	360 + 10 Pills	906.69€ 863.51€	Buy

Tell all your healthcare providers that you take LEVITRA. If you need emergency medical care for a heart problem, it will be important for your healthcare provider to know when you last took LEVITRA.

Other approaches

Phase 3 clinical trials included more than 834 elderly patients, and no differences in safety or effectiveness of LEVITRA 5, 10, or 20 mg were noted when these elderly patients were compared to younger patients. However, due to increased vardenafil concentrations in the elderly, a starting dose of 5 mg LEVITRA should be considered in patients ≥65 years of age. LEVITRA was administered to over 4430 men (mean age 56, range 18-89 years; 81% White, 6% Black, 2% Asian, 2% Hispanic and 9% Other) during controlled and uncontrolled clinical trials worldwide. Over 2200 patients were treated for 6 months or longer, and 880 patients were treated for at least 1 year. In placebo-controlled clinical trials, the discontinuation rate due to adverse events was 3.4% for LEVITRA compared to 1.1% for placebo.

Does Levitra have fewer side effects than Viagra?

When LEVITRA was taken as recommended in placebo-controlled clinical trials, the following adverse events were reported (see Table 5). Back pain was reported in 2.0% of patients treated with LEVITRA and 1.7% of patients on placebo. Placebo-controlled trials suggested a dose effect in the incidence of some adverse events (headache, flushing, dyspepsia, nausea, rhinitis) over the 5 mg, 10 mg, and 20 mg doses of LEVITRA. The following section identifies additional, less frequent events (<2%) reported during the clinical development of LEVITRA. Excluded from this list are those events that are infrequent and minor, those events that may be commonly observed in the absence of drug therapy, and those events that are not reasonably associated with the drug.

Levitra Brand

Most, but not all, of these patients had underlying anatomic or vascular risk factors for development of NAION, including but not necessarily limited to: low cup to disc ratio (“crowded disc”), age over 50, diabetes, hypertension, coronary artery disease, hyperlipidemia and smoking. It is not possible to determine whether these events are related directly to the use of PDE5 inhibitors, to the patient’s underlying vascular risk factors or anatomical defects, to a combination of these factors, or to other factors (see PRECAUTIONS, Information for Patients). Visual disturbances including vision loss (temporary or permanent), such as visual field defect, retinal vein occlusion, and reduced visual acuity, have also been reported rarely in post-marketing experience. It is not possible to determine whether these events are related directly to the use of LEVITRA. Seizure, seizure recurrence and transient global amnesia have been reported post-marketing in temporal association with LEVITRA. LEVITRA is a prescription medicine taken by mouth for the treatment of erectile dysfunction (ED) in men.

Dose	Typical Range (mg)	Frequency	Notes
Starting Dose	5 mg	Once daily	Adjust based on response
Maximum Dose	20 mg	Once per day	Under medical supervision
Common Side Effects	Headache, flushing	Usually mild	Dose adjustments may reduce side effects

ED is a condition where the penis does not harden and expand when a man is sexually excited, or when he cannot keep an erection. A man who has trouble getting or keeping an erection should see his doctor for help if the condition bothers him. LEVITRA may help a man with ED get and keep an erection when he is sexually excited.

Region	Attitudes towards female ED treatment	Accessibility	Comments
Western Countries	Increasing openness, off-label use	Medical access varies	Growing awareness
Asian Countries	More conservative, less acceptance	Limited availability	Cultural barriers
Middle East	Cultural restrictions on sexual health	Restricted access	Growing discussion needed
Latin America	Varying acceptance, some stigma	Access improving	More education needed

protect a man or his levitra 10mg tablets partner from sexually transmitted diseases, including HIV.

• Levitra is a prescription medication, and its safety in women is not fully established.
• Some women report increased sensation and blood flow in vaginal tissues after taking Levitra.
• The medication may interact with other drugs, so medical consultation is essential before use.
• Research indicates the potential benefits of PDE5 inhibitors like Levitra in women with sexual arousal issues.
• Levitra is not recommended for women during pregnancy or breastfeeding due to unknown risks.
• Psychological factors also significantly impact female sexual dysfunction, not just blood flow.
• Studies suggest that Levitra might improve sexual satisfaction when combined with counseling.
• Off-label use of Levitra in women is controversial and not supported by official guidelines.
• Women seeking sexual enhancement should consult healthcare providers for safe options.

Speak to your doctor about ways to guard against sexually transmitted diseases. serve as a male form of birth control LEVITRA is only for men with ED. LEVITRA is not for women or children. LEVITRA must be used only under a doctor’s care.

• Levitra works by relaxing blood vessels, which could theoretically improve sexual response in women.
• The drug's effect on female sexual function is still under investigation in clinical trials.
• Off-label prescribing can vary based on country laws and medical discretion.
• Studies have shown mixed results on the effectiveness of Levitra for women’s sexual health.
• Risks include potential cardiovascular effects, so a thorough medical assessment is recommended.
• Some women experience no significant changes after taking Levitra, highlighting individual variability.
• Erectile dysfunction medications are not guaranteed to enhance female sexual pleasure or desire.
• Researchers advise caution and emphasize evidence-based practice for women’s sexual health.
• Lifestyle factors such as stress, relationship issues, and hormonal imbalances also affect female arousal.

When a man is sexually stimulated, his body’s normal physical response is to increase blood flow to his penis.

How Do You Diagnosis Menopause?

Cases of sudden decrease or loss of hearing have been reported post-marketing in temporal association with the use of PDE5 inhibitors, including LEVITRA. In some cases, medical conditions and other factors were reported that may have also played a role in the otologic adverse events. In many cases, medical follow-up information was limited. It is not possible to determine whether these reported events are related directly to the use of LEVITRA, to the patient’s underlying risk factors for hearing loss, a combination of these factors, or to other factors (see PRECAUTIONS, Information for Patients). The maximum dose of LEVITRA for which human data are available is a single 120 mg dose administered to eight healthy male volunteers.

Are you currently using Vardenafil (Levitra, Staxyn)?

The majority of these subjects experienced reversible back pain/myalgia and/or “abnormal vision.” In cases of overdose, standard supportive measures should be taken as required. Renal dialysis is not expected to accelerate clearance because vardenafil is highly bound to plasma proteins and is not significantly eliminated in the urine. For most patients, the recommended starting dose of LEVITRA is 10 mg, taken orally approximately 60 minutes before sexual activity. The dose may be levitra drug increased to a maximum recommended dose of 20 mg or decreased to 5 mg based on efficacy and side effects. The maximum recommended dosing frequency is once per day.

What should I do if I miss a dose of vardenafil?

Sexual stimulation is required for a response to treatment. Geriatrics: A starting dose of 5 mg LEVITRA should be considered in patients ≥65 years of age (see CLINICAL PHARMACOLOGY, Pharmacokinetics in Special Populations and PRECAUTIONS). Hepatic Impairment: For patients with mild hepatic impairment (Child-Pugh A), no dose adjustment of LEVITRA is required. Vardenafil clearance is reduced in patients with moderate hepatic impairment (Child-Pugh B), and a starting dose of 5 mg LEVITRA is recommended. The maximum dose in patients with moderate hepatic impairment should not exceed 10 mg. LEVITRA helps increase blood flow to the penis and may help men with ED get and keep an erection satisfactory for sexual activity. Once a man has completed sexual activity, blood flow to his penis decreases, and his erection goes away. Talk to your doctor to decide if LEVITRA is right for you. LEVITRA has been shown to be effective in men over the age of 18 years who have erectile dysfunction, including men with diabetes or who have undergone prostatectomy. take any medicines called “nitrates” (See “What important information should you know about LEVITRA?”). Nitrates are commonly used to treat angina.

Warnings & Precautions

In those patients who are stable on alpha-blocker therapy, LEVITRA should be initiated at a dose of 5 mg (2.5 mg when used concomitantly with certain CYP3A4 inhibitors - see Drug Interactions). LEVITRA (vardenafil HCl) is formulated as orange, film-coated round tablets with debossed “BAYER” cross on one side and “10” and “20” on the other side equivalent to 10 mg and 20 mg of vardenafil, respectively. Vardenafil HCl (Levitra) 10mg tablets are supplied in bottles of 2, 4, 6, 12 and 18 tablets per bottle.Vardenafil HCl (Levitra) 20mg tablets are supplied in bottles of 2, 3, 4, 6, 12 and 18 tablets per bottle. Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature]. Bayer HealthCare Pharmaceuticals Inc.Wayne, NJ 07470 LEVITRA is a registered trademark of Bayer Aktiengesellschaft and is used under license by GlaxoSmithKline and Schering Corporation. Angina is a symptom of heart disease and can cause pain in your chest, jaw, or down your arm.Medicines called nitrates include nitroglycerin that is found in tablets, sprays, ointments, pastes, or patches.